SEITO Biologics AG
PrivateLast Round
Early Funding
Jun 3, 2025
Total Funding Raised
$3.44M
Company Overview
SEITO Biologics AG operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was an Early Funding round in June 2025.
SEITO Biologics AG is a biotechnology company that develops targeted cytokine therapies, specifically selective Treg cell engagers (TREX), to restore immune balance in patients with autoimmune and chronic-inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SEITO Biologics AG Comparables
Compare SEITO Biologics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dualyx | 81% | |
| Quell Therapeutics | 78% | |
| Egle Therapeutics | 77% |
For institutional investors. Book with your work email.
SEITO Biologics AG Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SEITO Biologics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lichtsteiner Foundation | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 67% MoM, reaching 2.1K.
- Nov 8, 2025
Monthly visitors increased 65% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
SEITO Biologics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SEITO Biologics AG's valuation, stock price, and market status.
Is SEITO Biologics AG a public or private company?
SEITO Biologics AG is a private company.
What is the current stock price of SEITO Biologics AG?
SEITO Biologics AG is a private company, so its shares have no public market price. Caplight tracks SEITO Biologics AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SEITO Biologics AG worth (valuation)?
Valuation information for SEITO Biologics AG is not publicly available.
Can I buy SEITO Biologics AG stock?
SEITO Biologics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SEITO Biologics AG's last funding round?
SEITO Biologics AG's most recent funding round was Early Funding on June 3, 2025.
Who are the main investors in SEITO Biologics AG?
Key investors in SEITO Biologics AG include Lichtsteiner Foundation.
Will SEITO Biologics AG IPO soon?
No public IPO plans have been announced for SEITO Biologics AG.
How can I track SEITO Biologics AG secondary market activity?
Caplight tracks bids, offers, and trades in SEITO Biologics AG's shares on secondary markets.